Title Biosimilar implementation : a progress report from FDA : hearing before the Subcommittee on Primary Health and Retirement Security of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, first session ... September 17, 2015.

Publication Info.

Online access
Connect to https://purl.fdlp.gov/GPO/gpo86316

Item Status

Description	1 online resource (iii, 40 pages) : illustrations.
Physical Medium	monochrome
Description	text file
Series	S. hrg. ; 114-700
	United States. Congress. Senate. S. hrg. ; 114-700.
Note	Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
	CRDP Program record.
Bibliography	Includes bibliographical references.
Subject	United States. Food and Drug Administration -- Rules and practice.
	United States. Food and Drug Administration.
	Parliamentary practice.
	Pharmaceutical biotechnology -- United States -- Management.
	Pharmaceutical biotechnology.
	United States.
	Management.
	Pharmaceutical biotechnology -- Government policy -- United States.
	Government policy.
	Drug development -- Government policy -- United States.
	Drug development.
	Drugs -- Generic substitution -- Government policy -- United States.
	Drugs -- Generic substitution.
Genre/Form	Legislative hearings.
	Rules.
	Legislative hearings.
Subject	Medication.
Other Form:	Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. Biosimilar implementation (OCoLC)1009576707
	Microfiche version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Retirement Security. Biosimilar implementation (OCoLC)1085907023
Gpo Item No.	1043-C (online)
Sudoc No.	Y 4.L 11/4:S.HRG.114-700